These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47. Different HLA class II associations in ulcerative colitis patients with and without primary sclerosing cholangitis. Karlsen TH; Boberg KM; Vatn M; Bergquist A; Hampe J; Schrumpf E; Thorsby E; Schreiber S; Lie BA; Genes Immun; 2007 Apr; 8(3):275-8. PubMed ID: 17301827 [TBL] [Abstract][Full Text] [Related]
48. Prevalence and clinical significance of anti-lactoferrin autoantibodies in inflammatory bowel diseases and primary sclerosing cholangitis. Roozendaal C; Horst G; Pogány K; van Milligen de Wit AW; Kleibeuker JH; Haagsma EB; Limburg PC; Kallenberg CG Adv Exp Med Biol; 1998; 443():313-9. PubMed ID: 9781375 [TBL] [Abstract][Full Text] [Related]
49. Role of immune factors in the pathogenesis of primary sclerosing cholangitis. Chapman RW Semin Liver Dis; 1991 Feb; 11(1):1-4. PubMed ID: 2047883 [No Abstract] [Full Text] [Related]
50. HLA antigens and pANCA define ulcerative colitis as a genetically heterogeneous disorder. Perri F; Annese V; Piepoli A; Napolitano G; Lombardi G; Ciavarella G; Di Giorgio G; Andriulli A Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):56-61. PubMed ID: 9615268 [TBL] [Abstract][Full Text] [Related]
51. "Atypical p-ANCA" in IBD and hepatobiliary disorders react with a 50-kilodalton nuclear envelope protein of neutrophils and myeloid cell lines. Terjung B; Spengler U; Sauerbruch T; Worman HJ Gastroenterology; 2000 Aug; 119(2):310-22. PubMed ID: 10930366 [TBL] [Abstract][Full Text] [Related]
52. Genetic heterogeneity in ulcerative colitis. Lashner BA Am J Gastroenterol; 1994 Nov; 89(11):1927-8. PubMed ID: 7942713 [No Abstract] [Full Text] [Related]
53. Autoantibodies against the specific epitope of human tropomyosin(s) detected by a peptide based enzyme immunoassay in sera of patients with ulcerative colitis show antibody dependent cell mediated cytotoxicity against HLA-DPw9 transfected L cells. Sakamaki S; Takayanagi N; Yoshizaki N; Hayashi S; Takayama T; Kato J; Kogawa K; Yamauchi N; Takemoto N; Nobuoka A; Ayabe T; Kohgo Y; Niitsu Y Gut; 2000 Aug; 47(2):236-41. PubMed ID: 10896915 [TBL] [Abstract][Full Text] [Related]
55. IgA/IgG pemphigus with infiltration of neutrophils and eosinophils in an ulcerative colitis patient. Uchiyama R; Ishii N; Arakura F; Kiniwa Y; Nakazawa K; Uhara H; Hashimoto T; Okuyama R Acta Derm Venereol; 2014 Nov; 94(6):737-8. PubMed ID: 24604005 [No Abstract] [Full Text] [Related]
56. [Peculiarities of the clinical course of ulcerative colitis, depending on the spectrum of cross-linked autoantibodies from the same family to antigens of neutrophils]. Sagynbaeva VÉ Eksp Klin Gastroenterol; 2014; (12):37-41. PubMed ID: 26058110 [TBL] [Abstract][Full Text] [Related]
57. Association of primary sclerosing cholangitis with HLA-B8. Chapman RW; Varghese Z; Gaul R; Patel G; Kokinon N; Sherlock S Gut; 1983 Jan; 24(1):38-41. PubMed ID: 6600227 [TBL] [Abstract][Full Text] [Related]
58. Anti-neutrophil antibodies in primary sclerosing cholangitis. Terjung B; Worman HJ Best Pract Res Clin Gastroenterol; 2001 Aug; 15(4):629-42. PubMed ID: 11492972 [TBL] [Abstract][Full Text] [Related]
59. Identification and characterization of autoantibodies against catalase and alpha-enolase in patients with primary sclerosing cholangitis. Orth T; Kellner R; Diekmann O; Faust J; Meyer zum Büschenfelde KH; Mayet WJ Clin Exp Immunol; 1998 Jun; 112(3):507-15. PubMed ID: 9649223 [TBL] [Abstract][Full Text] [Related]
60. Hepatobiliary changes in patients with ulcerative colitis, with special reference to the effect of proctocolectomy. Aitola P; Matikainen M; Mattila J Scand J Gastroenterol; 1998 Feb; 33(2):113-7. PubMed ID: 9517518 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]